For citations:
Alugishvili M.Z., Kozulin V.Y., Usova E.A., Gevorkova L.V., Mitrofanova L.B., Gordeev M..., Panov A.V. Evaluation of antiproliferative efficacy of valsartan in patients with coronary artery disease during myocardial revascularisation (the PROLIV study). "Arterial’naya Gipertenziya" ("Arterial Hypertension"). 2012;18(4):334-343. (In Russ.) https://doi.org/10.18705/1607-419X-2012-18-4-334-343
Email this article 